tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market

Allergy Therapeutics (AGY) Financial Statements

Compare
18 Followers

Allergy Therapeutics Financial Overview

Allergy Therapeutics's market cap is currently £740.91M. The company's EPS TTM is p; its P/E ratio is -3.26; Allergy Therapeutics is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue£ 55.04M£ 55.20M£ 59.59M£ 72.77M£ 84.33M
Gross Profit£ 25.13M£ 29.74M£ 32.69M£ 48.95M£ 61.80M
Operating Income£ -29.50M£ -35.26M£ -34.85M£ -13.00M£ 4.03M
EBITDA£ -29.43M£ -30.74M£ -36.24M£ -8.69M£ 7.61M
Net Income£ -40.13M£ -40.22M£ -43.07M£ -13.78M£ 2.89M
Balance Sheet
Cash & Short-Term Investments£ 12.79M£ 12.91M£ 14.85M£ 20.52M£ 40.27M
Total Assets£ 67.54M£ 64.83M£ 66.77M£ 72.95M£ 88.09M
Total Debt£ 60.09M£ 30.99M£ 35.99M£ 10.53M£ 11.17M
Net Debt£ 47.50M£ 18.07M£ 21.14M£ -9.99M£ -29.10M
Total Liabilities£ 95.74M£ 61.12M£ 64.70M£ 35.18M£ 39.55M
Stockholders' Equity£ -28.19M£ 3.71M£ 2.07M£ 37.77M£ 48.53M
Cash Flow
Free Cash Flow£ -31.98M£ -35.54M£ -35.59M£ -17.17M£ 5.95M
Operating Cash Flow£ -28.72M£ -32.14M£ -30.92M£ -14.11M£ 8.52M
Investing Cash Flow£ -3.15M£ -1.20M£ -4.67M£ -3.06M£ -2.76M
Financing Cash Flow£ 32.04M£ 31.43M£ 29.91M£ -2.64M£ -2.03M
Currency in GBP

Allergy Therapeutics Earnings and Revenue History

Allergy Therapeutics Debt to Assets

Allergy Therapeutics Cash Flow

Allergy Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.